Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
World J Biol Psychiatry ; 11(2 Pt 2): 519-21, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20218807

RESUMEN

Queatiapine has been used in bipolar mania and most recently in bipolar depression with good results; however, its use in maintenance treatment has not been established yet. A case of a woman suffering from bipolar I disorder who underwent bone marrow transplantation twice because of leukaemia is presented. The use of quetiapine as a monotherapy was efficient and safe and proved to be a good treatment in mood stabilization for 1 year.


Asunto(s)
Antipsicóticos/uso terapéutico , Trastorno Bipolar/tratamiento farmacológico , Trasplante de Médula Ósea/psicología , Dibenzotiazepinas/uso terapéutico , Trastorno Bipolar/complicaciones , Femenino , Humanos , Leucemia Mieloide Aguda/complicaciones , Leucemia Mieloide Aguda/psicología , Leucemia Mieloide Aguda/terapia , Persona de Mediana Edad , Fumarato de Quetiapina , Resultado del Tratamiento
2.
Eur Arch Psychiatry Clin Neurosci ; 258(4): 217-25, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18297425

RESUMEN

BACKGROUND: Executive function deficits in depression implicate involvement of frontal-striatal circuits. However, studies of hypothalamic-pituitary-axis (HPA) function suggest that stress-related brain changes of hippocampus may also implicate prefrontal-hippocampal circuits, which may explain the profile of both executive dysfunction and memory deficits. In this study we examined the performance of patients with major depressive disorder (MDD) on tasks of memory and executive function in relation to melancholic features and to cortisol levels. Our hypothesis was that raised cortisol levels in melancholic patients would correlate with these deficits. METHOD: Forty female MDD patients, 20 having melancholic features (MEL vs. Non-MEL), and 20 sex-age- and education-matched normal controls were investigated using the Cambridge neuropsychological test automated battery (CANTAB), to assess memory (paired associative learning, PAL; short-term recognition memory, SRM) and executive (intradimensional/extradimensional set-shifting, ID/ED; Stockings of Cambridge, SOC) functions. Plasma and salivary cortisol levels were measured. RESULTS: The MDD patients performed worse than controls on PAL and both executive tasks. The MEL group differed from controls on all tests, and differed from the non-MEL only at the ED stage of the ID/ED task. Patient cortisol levels were within the normal range and did not correlate with neuropsychological performance for any group. CONCLUSIONS: MDD patients showed neuropsychological deficits on tasks of executive function and memory, supporting the model of frontal-temporal dysfunction. MEL vs. non-MEL performed worse overall and demonstrated a qualitative difference in set shifting, perhaps implicating more extensive prefrontal involvement. Cortisol levels did not correlate with depression severity or the observed deficits.


Asunto(s)
Depresión/sangre , Depresión/fisiopatología , Hidrocortisona/metabolismo , Pruebas Neuropsicológicas , Adulto , Análisis de Varianza , Antidepresivos/uso terapéutico , Aprendizaje por Asociación/fisiología , Distribución de Chi-Cuadrado , Depresión/tratamiento farmacológico , Femenino , Humanos , Escala del Estado Mental , Persona de Mediana Edad , Solución de Problemas/fisiología , Saliva/efectos de los fármacos , Saliva/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA